ResearcherCornell UniversityNo recent work listed
Mauro Ferrari B
Matched on ORCID iD 0000-0001-7042-0236; OpenAlex author ID A5070051249. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 36
2014: 3 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: 2 papers
Papers 6
- SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy. Co-author DOI 10.1158/1078-0432.ccr-17-3435↗
- A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-17-3668↗
- Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2017.06.026↗
- Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. Co-author DOI 10.1088/1478-3975/11/6/065002↗
- Transport properties of pancreatic cancer describe gemcitabine delivery and response. Co-author DOI 10.1172/jci73455↗
- Human equilibrative nucleoside transporter-1 knockdown tunes cellular mechanics through epithelial-mesenchymal transition in pancreatic cancer cells. Last author DOI 10.1371/journal.pone.0107973↗
Closest collaborators
The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Eugene Jon Koay · 6 shared papers, 2014–2018 · strength 0.29
- Paper SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy. DOI 10.1158/1078-0432.ccr-17-3435↗
- Paper Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal ad… DOI 10.1016/j.canlet.2017.06.026↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Ya’an Kang · 5 shared papers, 2014–2018 · strength 0.24
- Paper SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy. DOI 10.1158/1078-0432.ccr-17-3435↗
- Paper Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal ad… DOI 10.1016/j.canlet.2017.06.026↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Jason B. Fleming · 4 shared papers, 2014–2018 · strength 0.18
- Paper SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy. DOI 10.1158/1078-0432.ccr-17-3435↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Haifa Shen · 4 shared papers, 2014–2018 · strength 0.18
- Paper SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy. DOI 10.1158/1078-0432.ccr-17-3435↗
- Paper Human equilibrative nucleoside transporter-1 knockdown tunes cellular mechanics through epithelial-mesenchymal transiti… DOI 10.1371/journal.pone.0107973↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Yeon‐Ju Lee · 3 shared papers, 2014–2018 · strength 0.16
- Paper Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal ad… DOI 10.1016/j.canlet.2017.06.026↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Human equilibrative nucleoside transporter-1 knockdown tunes cellular mechanics through epithelial-mesenchymal transiti… DOI 10.1371/journal.pone.0107973↗
- Milind M. Javle · 3 shared papers, 2014–2018 · strength 0.11
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Paper Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. DOI 10.1088/1478-3975/11/6/065002↗
- Matthew H. G. Katz · 3 shared papers, 2014–2018 · strength 0.11
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Paper Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. DOI 10.1088/1478-3975/11/6/065002↗
- Eric Peter Tamm · 3 shared papers, 2014–2018 · strength 0.11
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Paper Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. DOI 10.1088/1478-3975/11/6/065002↗
- Huamin Wang · 3 shared papers, 2014–2018 · strength 0.11
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Paper Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. DOI 10.1088/1478-3975/11/6/065002↗
- Deyali Chatterjee · 3 shared papers, 2014–2018 · strength 0.11
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Paper Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. DOI 10.1088/1478-3975/11/6/065002↗
- Robert A. Wolff · 3 shared papers, 2014–2018 · strength 0.11
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Paper Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. DOI 10.1088/1478-3975/11/6/065002↗
- Priya Bhosale · 3 shared papers, 2014–2018 · strength 0.11
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Paper Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. DOI 10.1088/1478-3975/11/6/065002↗
- Gauri Rajani Varadhachary · 3 shared papers, 2014–2018 · strength 0.11
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Paper Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. DOI 10.1088/1478-3975/11/6/065002↗
- Christopher H. Crane · 3 shared papers, 2014–2018 · strength 0.11
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Paper Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. DOI 10.1088/1478-3975/11/6/065002↗
- Jeffrey E. Lee · 3 shared papers, 2014–2018 · strength 0.11
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Transport properties of pancreatic cancer describe gemcitabine delivery and response. DOI 10.1172/jci73455↗
- Paper Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. DOI 10.1088/1478-3975/11/6/065002↗
- Mohamed Zaid · 2 shared papers, 2017–2018 · strength 0.11
- Paper Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal ad… DOI 10.1016/j.canlet.2017.06.026↗
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Anirban Maitra · 2 shared papers, 2014–2018 · strength 0.08
- Paper A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarci… DOI 10.1158/1078-0432.ccr-17-3668↗
- Paper Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. DOI 10.1088/1478-3975/11/6/065002↗
- Feng Wang · 1 shared paper, 2018 · strength 0.07
- Xiaojun Xia · 1 shared paper, 2018 · strength 0.07
- Ryan Michael Thomas · 2 shared papers, 2014 · strength 0.06
- Carlotta Borsoi · 1 shared paper, 2017 · strength 0.06
- Biana Godin · 1 shared paper, 2017 · strength 0.06
- James L. Abbruzzese · 2 shared papers, 2014 · strength 0.06
- Rong Chen · 2 shared papers, 2014 · strength 0.06
- Vijaya N. R. Gottumukkala · 2 shared papers, 2014 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.